Technology Breakthrough urine test can detect brain tumors early
Only 0.03 percent of vaccinated people test positive for COVID-19, Wisconsin officials say
Only 0.03 percent of vaccinated people in Wisconsin have tested positive for COVID-19, officials say. The state had 605 "breakthrough" COVID-19 cases among the 1.8 million residents who are fully vaccinated, Wisconsin Department of Health Services spokesperson Jennifer Miller told The Hill.The breakthrough in the Badger State was reported two weeks after people were fully vaccinated. Miller said the cases are among 82,396 confirmed and probable cases since Jan. 18.
The sooner cancer is diagnosed,are for patients because treatment can start immediately. Doctors often look for markers that would confirm the presence of a tumor, but not all cancers are the same. Different biomarkers are used to detect different types of malignant growths in tandem with other tests to establish a correct diagnosis.
One type of tumor that’s difficult to catch early is brain cancer, as patients usually get a CT or MRI scan only after developing neurological symptoms. Doctors would recommend the scan to analyze the brain’s structure, at which point they’d detect and diagnose the abnormal tissue. Once the diagnosis arrives, it might be too late for surgery to completely remove the growth. In turn, this would reduce the patient’s chances of survival.
Conquering cancer requires new ideas and proven strategies
Americans living with cancer, including brain tumors, need more than hope — they need the federal government to be strategic. National Brain Tumor Society (NBTS), where I am chief of community & government relations, is the nation's largest brain tumor patient advocacy organization. NBTS works with the executive branch and Congress every May and throughout the year to advance specific policies that will improve the lives of people living with brain tumors.
A team of scientists from the Nagoya University set out to fix this problem and discovered a breakthrough urine test that might significantly hasten brain cancer diagnoses and save lives.
published in ( ), researchers at the Nagoya University researchers came up with a microRNA urine test that can detect brain cancer with 97% specificity.
MicroRNAs are small nucleic acid molecules that are released by different cells in bodily fluids such as blood and urine. The researchers focused on these tiny particles and developed a process for finding the molecules that could act as an early warning signfor brain tumors.
“Urine can be collected easily without putting a burden on the human body,” Nagoya University Associate Professor Atsushi Natsume said. “Urine-based liquid biopsy hadn’t been fully investigated for patients with brain tumors because none of the conventional methodologies can extract microRNAs from urine efficiently in terms of varieties and quantities. So, we decided to develop a device capable of doing it.”
Researchers boost robotic arm movement by adding a sense of touch
Nathan Copeland knows a thing or two about brain implants. More than a decade after a car crash left him paralyzed from the chest down, Copeland enrolled in a medical trial that helped him to regain his sense of touch. The breakthrough saw scientists implant chips in his brain that allowed him to control a robotic hand. Back in 2016, Copeland flexed his new appendage by fist-bumping then President Barack Obama. Now, in his mid-30s, he's becomeThanks to a new brain interface experiment, Copeland was able to feel the sensation of touch when his robotic hand came into contact with a surface or object.
To capture the microRNA that might be traveling through urine, the scientists created a device made up of 100 million zinc oxide nanowires. The device can be mass-produced and it can be sterilized for medical usage. Only one millimeter of urine is required for the gadget to extract a large amount of microRNA from a sample, far exceeding what’s available in the industry.
The authors explained that many microRNAs from brain tumors exist in urine in a stable state. They used their device to analyze samples from brain cancer patients and controls. The study says the device can diagnose brain tumors with a sensitivity of 100% and a specificity of 97%, regardless of the size and malignancy of the tumors. Sensitivity measures the proportion of positive diagnostics correctly identified, while specificity measures the correct true negative diagnostics in a test. That means the study correctly identified 100% of cancer patients and 97% of noncancer volunteers.
The Nagoya University scientists believe the new test might be used as a marker to catch various types of brain cancer early. “In the future, by a combination of artificial intelligence and telemedicine, people will be able to know the presence of cancer, whereas doctors will be able to know the status of cancer patients just with a small amount of their daily urine,” Dr. Natsume said.
Bernard Tapie: His family makes a big focus on his health status
© SIPA Bernard Tapie: his family makes a big focus on his state of health since the entourage of Bernard Tapie gave New worries about his state of health, his family has decided to put things clear. No, the businessman did not drop his arms and he is not dying. It's anxiety around Bernard Tapie's health status. If the businessman has already been fighting for years against a double cancer of the esophagus and the stomach , his case has aggravated .
The full study is available.
The same mRNA technology used in COVID-19 vaccines could help treat cancer .
Fighting COVID-19 proved a boon to cancer research. Here's how scientists are using the same mRNA technology to attack tumors.About a year before Fentress got his double shots of COVID-19 vaccine made with mRNA, the painting contractor was infused with a personalized version to fight his cancer.